EPISODE · Dec 1, 2014 · 7 MIN
Is There a Future for Cyclooxygenase-2 Inhibition in Non-Small Cell Lung Cancer?
from Journal of Clinical Oncology (JCO) Podcast
This podcast reviews the available data from clinical trials using cyclooxygenase-2 inhibition with chemotherapy in non-small cell lung cancer and provides a perspective on patient selection and future directions.
Embed this episode
NOW PLAYING
Is There a Future for Cyclooxygenase-2 Inhibition in Non-Small Cell Lung Cancer?
0:00
7:50
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 7 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on December 1, 2014.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!